mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.2 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.2 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
-0.23 |
0.2 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |